About Linux Life Sciences
Linux Life Sciences is a company founded in 2019. The company has 88 employees. Linux Life Sciences offers products and services including Pharmaceuticals and Nutraceuticals.
- Employees 88
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Social LinkedIn Facebook Instagram
- Legal Name Linux Life Sciences Private Limited
- Date of Incorporation 19 Mar, 2015
- Jurisdiction Puducherry, India
- Annual Revenue₹47.40 Cr
FY 2025 · +52% YoY
- Net Profit₹4.66 Cr
FY 2025 · 10% margin
- EBITDA₹7.30 Cr
FY 2025 · 15% margin
- Employee Count88
Associated legal entities of Linux Life Sciences
Linux Life Sciences operates through Linux Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Linux Life Sciences Private Limited CIN U74900PY2015PTC002951 | Active | 19 Mar 2015 | Puducherry, Puducherry | ₹47.4 Cr | 88 | 3 | View details |
Products & Services of Linux Life Sciences
Linux Life Sciences offers a comprehensive portfolio of products and services, including Pharmaceuticals and Nutraceuticals.
Pharmaceuticals, including anti-infectives and oral liquids, are manufactured and supplied to address health solutions in domestic and international markets.
Nutraceuticals are developed and marketed using contemporary facilities to meet global standards for efficacy and quality.
Board of directors of Linux Life Sciences Private Limited (Linux Life Sciences)
Linux Life Sciences Private Limited is the primary company behind Linux Life Sciences. The board of Linux Life Sciences Private Limited currently have 3 directors; the longest-serving is Anandkumar Sundharam, appointed in 2019. 9 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anandkumar Sundharam DIN 03093555 | Director | 26 Aug 2019 | 7 yrs 1 mo | Linux Life Sciences Private Limited |
| Hariharan Parameswaran DIN 03182300 | Director | 26 Aug 2019 | 7 yrs 1 mo | Linux Life Sciences Private Limited |
| Keerthivasan DIN 03093536 | Director | 26 Aug 2019 | 7 yrs 1 mo | Linux Life Sciences Private Limited |
Financials of Linux Life Sciences
Figures of Linux Life Sciences Private Limited, the primary company behind Linux Life Sciences, for FY 2025. Revenue was ₹47.40 Cr (+52% year on year). Net profit was ₹4.66 Cr (10% margin). EBITDA was ₹7.30 Cr (15% margin). Revenue has grown at a compounded annual rate of +42% over three years.
- ₹47.40 CrRevenue · FY 2025 · +52% YoY
- ₹4.66 CrNet profit · 10% margin
- ₹7.30 CrEBITDA · 15% margin
- ₹9.86 CrPaid-up capital
- 88Employees (provident fund records)
- +42%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Linux Life Sciences Private Limited are on its company page.
Detailed financial statements for Linux Life Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Linux Life Sciences
10 companies that operate in the same segment as Linux Life Sciences (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Linux Life Sciences
Linux Life Sciences was founded in 2019.
Linux Life Sciences has 88 employees.
The primary company behind Linux Life Sciences, Linux Life Sciences Private Limited, reported revenue of ₹47.40 Cr for FY 2025, up 52% year on year.
Since 2007, Linux Life Sciences has been positioned at the forefront of pharmaceutical and nutraceutical production in Puducherry, India, with a dedication to delivering precise health solutions for domestic and international markets. Quality is ensured through rigorous manufacturing practices and adherence to global standards, while products like anti-infectives and nutraceuticals are supplied to over 25 countries. Commitments to efficacy, on-time delivery, and core values such as integrity and hard work are maintained, contributing to enhanced global health outcomes.
Linux Life Sciences offers Pharmaceuticals and Nutraceuticals.
Linux Life Sciences operates through Linux Life Sciences Private Limited.
The legal entities of Linux Life Sciences currently have 3 directors, including Anandkumar Sundharam, Hariharan Parameswaran, Keerthivasan.